HIV-1
|
Rag2-/-γc-/-
|
[44, 46, 48–51, 55–61, 63–65]
|
HIV-1
|
NOD/SCIDγc-/- (hNOG)
|
[43, 66, 67, 72, 73]
|
HIV-1
|
NOD/SCIDγc-/- (hNSG)
|
[68–71, 74–76]
|
HIV-1
|
NOD/SCID BLT
|
[42, 45, 77–79]
|
HIV-1
|
NOD/SCIDγc-/- (hNSG) BLT
|
[42, 81]
|
HIV-1
|
Rag1-/-γc-/-
|
[23]
|
HTLV
|
NOD/SCID
|
[25]
|
EBV
|
Rag2-/-γc-/-
|
[17, 122]
|
EBV
|
NOD/SCIDγc-/- (hNOG)
|
[27, 28]
|
EBV
|
NOD/SCIDγc-/- (hNSG)
|
[29]
|
EBV
|
NOD/SCID BLT
|
[30]
|
EBV
|
NOD/SCID
|
[26]
|
KSHV
|
NOD/SCID
|
[31, 32]
|
Dengue Virus
|
Rag2-/-γc-/-
|
[35]
|
Dengue Virus
|
NOD/SCID
|
[36]
|
HSV-2
|
Rag2-/-γc-/-
|
[34]
|
rAd-HCV
|
NOD/SCIDγc-/- (hNSG)
|
[37]
|
hCMV
|
NOD/SCIDγc-/- (hNSG)
|
[33]
|
HCV
|
Rag2-/-γc-/-Fah-/-
|
[40]
|
HBV
|
Rag2-/-γc-/-Fah-/-
|
[40]
|
HBV
|
Rag2-/-γc-/-uPa-/-
|
[123]
|
Bacteria:
| | |
Salmonella typhi
|
Rag2-/-γc-/-
|
[124]
|
Non-infectious agents:
| | |
Tetanus toxoid
|
Rag2-/-γc-/-
|
[17, 97]
|
Haemophilus influenza B conjugate vaccine
|
Rag2-/-γc-/-
|
[46]
|
Hepatitis B surface antigen vaccine
|
Rag2-/-γc-/-
|
[97]
|
Toxic shock syndrome toxin 1
|
NOD/SCID BLT
|
[30]
|
2,4-dinitrophenyl hapten-keyhole limpet hemocyanin
|
NOD/SCID BLT
|
[47]
|